Related Experiment Video
Updated: Sep 18, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
HOTTIP suppresses ferroptosis via mediating DGCR8/miR‑214‑3p/GPX4 regulatory axis in osteosarcoma
Shou-Chang Ding1, Chuan-Jian Shi1, Feng-Xiang Pang2
1Cancer Center, Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong 518000, P.R. China.
Abstract:
Osteosarcoma (OS) is the most common primary bone malignancy in children and adolescents and the current typical strategy remains unsatisfactory in clinical practice. Ferroptosis has been considered as a novel form of programmed cell death in eukaryotic cells, which is characterized by iron‑dependent lipid peroxidation accumulation. The emergence of ferroptosis brings great hope to develop the potential therapeutic targets for OS patients. Long noncoding (lnc)RNA HOXA transcript at the distal tip (HOTTIP) has been identified as an oncogene to facilitate tumorigenesis in OS. Whether ferroptosis participates in this lncRNA mediated OS tumorigenesis is not fully understood. In the present study, HOTTIP was found to be downregulated in the Erastin‑treated OS cells. Silence of HOTTIP promoted, while ectopic expression of HOTTIP suppressed, ferroptosis in OS cells in vitro and in vivo. Mechanically, HOTTIP recruited the RNA binding protein DiGeorge Critical Region 8 (DGCR8) and influenced its protein stability, which disrupted miR‑214‑3p biogenesis and facilitated the de‑repression of glutathione peroxidase 4 transcription, eventually leading to preventing ferroptosis. Taken together, the present study demonstrated that HOTTIP suppressed ferroptosis in OS cells via DGCR8/micro RNA 214‑3p/GPX4 regulatory axis, which might provide insights to develop HOTTIP as a promising therapeutic target for OS patients.
Insights
Long noncoding RNA HOTTIP suppresses ferroptosis in osteosarcoma by regulating the DGCR8/miR-214-3p/GPX4 axis. This finding offers potential therapeutic targets for osteosarcoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Research
Background:
- Osteosarcoma (OS) is a common pediatric bone cancer with limited treatment options.
- Ferroptosis, a novel form of programmed cell death, presents a potential therapeutic avenue for OS.
- The role of long noncoding RNA HOXA transcript at the distal tip (HOTTIP) in OS ferroptosis remains unclear.
Purpose of the Study:
- To investigate the role of HOTTIP in ferroptosis of osteosarcoma cells.
- To elucidate the molecular mechanism by which HOTTIP influences ferroptosis in OS.
- To explore HOTTIP as a potential therapeutic target for osteosarcoma.
Main Methods:
- In vitro and in vivo experiments using osteosarcoma cell lines and animal models.
- Manipulation of HOTTIP expression (silencing and ectopic expression).
- Analysis of ferroptosis markers, DGCR8 protein stability, miR-214-3p biogenesis, and GPX4 transcription.
Main Results:
- HOTTIP was downregulated in Erastin-treated OS cells.
- HOTTIP downregulation promoted ferroptosis, while its overexpression suppressed it.
- HOTTIP recruited DGCR8, affecting miR-214-3p biogenesis and GPX4 transcription, thereby preventing ferroptosis.
Conclusions:
- HOTTIP acts as a suppressor of ferroptosis in osteosarcoma cells.
- The HOTTIP/DGCR8/miR-214-3p/GPX4 axis is a key regulatory pathway in OS ferroptosis.
- HOTTIP represents a promising therapeutic target for osteosarcoma.
Related Concept Videos
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Hedgehog Signaling Pathway
Abnormal Proliferation

